Regional Block for Post-mastectomy Analgesia
ConditionAnalgesia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-64
SponsorZagazig University
About this trial
A large number of patients undergoing major surgical procedures for the management of breast cancer complain of acute and chronic postoperative pain. Morphine administration for acute pain after mastectomy surgery has many side effects. Regional block techniques, such as paravertebral block and thoracic epidural anaesthesia, have possible complications and technical difficulties. So, we will discuss adding dexmedetomidine as an adjuvant to bupivacaine for serratus-intercostal versus erector-spinae plane block to relieve post-mastectomy pain.
Eligibility criteria
Qualifiers
Unilateral mastectomy operations.
Body mass index less than 35 kg per square meter.
American Society of Anesthesiologists physical status grade I-II.
Disqualifiers
Patient refusal.
History of chronic pain therapy.
Infection at the injection site.
Trial design
Treatments tested in this trial
- Serratus-intercostal plane block
- Erector spinae plane block
- Dexmedetomidine Injection
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov